Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Cefotaxime as the potential cause of transient acquired von Willebrand syndrome

Haj, M. A., Murch, N., Bowen, Derrick John, Sati, H. I., Beddal, A., Benton, A. and Collins, Peter William 2006. Cefotaxime as the potential cause of transient acquired von Willebrand syndrome. European Journal of Haematology 76 (5) , pp. 440-443. 10.1111/j.0902-4441.2006.t01-1-EJH2386.x

Full text not available from this repository.


Acquired von Willebrand syndrome (AvWS) is a relatively rare bleeding disorder. It has been reported in association with myeloproliferative disorders, autoimmune diseases, plasma cell dyscrasias and certain drugs. Cefotaxime is a third generation cephalosporin widely used for surgical prophylaxis and as empirical treatment of bacterial meningitis. We report a case of a transient AvWS in association with cefotaxime therapy.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Systems Immunity Research Institute (SIURI)
Subjects: R Medicine > R Medicine (General)
Uncontrolled Keywords: acquired; von Willebrand syndrome; cefotaxime
Publisher: Wiley-Blackwell
ISSN: 0902-4441
Last Modified: 04 Jun 2017 06:14

Citation Data

Cited 6 times in Google Scholar. View in Google Scholar

Cited 4 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item